- More than 60% of revenues are realized in gastroenterology
- Revenues are now generated by both physician prescriptions, pharmacists’ recommendations and the direct requests of patients
- A presence in 70 countries, with 3 key emerging markets (China, Russia and Algeria), making us a major player in gastrointestinal (GI) disorders